Literature DB >> 9226366

Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees.

Q Cao1, M Martinez, J Zhang, A R Sanders, J A Badner, A Cravchik, C J Markey, E Beshah, J J Guroff, M E Maxwell, D M Kazuba, R Whiten, L R Goldin, E S Gershon, P V Gejman.   

Abstract

We have investigated whether there is a locus on chromosome 6 that confers an increased susceptibility to schizophrenia using a two-stage approach and nonparametric linkage analysis. Allele sharing identical by descent (IBD) and multipoint maximum likelihood score (MLS) statistics were employed. Results from two tested data sets, a first data set, or genome scanning data set, and a second replication data set, show excess allele sharing for multiple markers in 6q, a chromosomal region not previously reported as linked to schizophrenia. In our genome scanning data set, excess allele sharing was found for markers on 6q13-q26. The greatest allele sharing was at interval 6q21-q22.3 at marker D6S416 (IBD percentage 69; P = 0.00024). The multipoint MLS values were greater than 2.4 in the 11.4-cM interval delimited by D6S301 and D6S303, with a maximum value of 3.06 close to D6S278 and of 3.05 at D6S454/D6S423. We did not confirm, however, the previously described linkage in 6p, when tested in the systematic genome scanning data set. The replication data set also showed excess allele sharing in chromosomal area 6q13-q26, which overlapped with the aforementioned positive linkage area of the genome scanning data set. The highest sharing of the second data set was at D6S424 (IBD percentage 64; P = 0.0004), D6S283 (IBD percentage 62; P = 0.0009), and D6S423 (IBD percentage 63; P = 0.0009). Multipoint MLS analysis yielded MLS values greater than 1 in an area of about 35 cM, which overlaps with the MLS multipoint area of linkage from the genome scanning data set. The multipoint MLS at the D6S454/D6S423 locus was 2.05. In the second data set, the maximum multipoint MLS was located about 10 cM centromeric from the maximum of the genome scanning data set, at the interval D6S424-D6S275 (2.35). Our results provide very suggestive evidence for a susceptibility locus for schizophrenia in chromosome 6q from two independent data sets.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9226366     DOI: 10.1006/geno.1997.4815

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  45 in total

Review 1.  Genetic analyses of schizophrenia.

Authors:  C N Pato; K M Schindler; M T Pato
Journal:  Curr Psychiatry Rep       Date:  2000-04       Impact factor: 5.285

2.  Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23.

Authors:  H M Gurling; G Kalsi; J Brynjolfson; T Sigmundsson; R Sherrington; B S Mankoo; T Read; P Murphy; E Blaveri; A McQuillin; H Petursson; D Curtis
Journal:  Am J Hum Genet       Date:  2001-03       Impact factor: 11.025

Review 3.  Genetics of schizophrenia and the new millennium: progress and pitfalls.

Authors:  M Baron
Journal:  Am J Hum Genet       Date:  2001-01-17       Impact factor: 11.025

4.  A schizophrenia-susceptibility locus at 6q25, in one of the world's largest reported pedigrees.

Authors:  E Lindholm; B Ekholm; S Shaw; P Jalonen; G Johansson; U Pettersson; R Sherrington; R Adolfsson; E Jazin
Journal:  Am J Hum Genet       Date:  2001-05-25       Impact factor: 11.025

Review 5.  Molecular genetics of schizophrenia: a critical review.

Authors:  Neeraj Berry; Vaidehi Jobanputra; Hemraj Pal
Journal:  J Psychiatry Neurosci       Date:  2003-11       Impact factor: 6.186

Review 6.  Linkage studies of schizophrenia.

Authors:  Brien Riley
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 7.  Trace amine-associated receptors and their ligands.

Authors:  R Zucchi; G Chiellini; T S Scanlan; D K Grandy
Journal:  Br J Pharmacol       Date:  2006-11-06       Impact factor: 8.739

8.  Evidence for a role of the NOS1AP (CAPON) gene in schizophrenia and its clinical dimensions: an association study in a South American population isolate.

Authors:  Barbara Kremeyer; Jenny García; Hanna Kymäläinen; Naomi Wratten; Gabriel Restrepo; Carlos Palacio; Ana Lucía Miranda; Carlos López; Margarita Restrepo; Gabriel Bedoya; Linda M Brzustowicz; Jorge Ospina-Duque; María Patricia Arbeláez; Andrés Ruiz-Linares
Journal:  Hum Hered       Date:  2008-12-15       Impact factor: 0.444

9.  DTNBP1 (Dystrobrevin binding protein 1) and schizophrenia: association evidence in the 3' end of the gene.

Authors:  Jubao Duan; Maria Martinez; Alan R Sanders; Cuiping Hou; Gregory J Burrell; Aaron J Krasner; Daniel B Schwartz; Pablo V Gejman
Journal:  Hum Hered       Date:  2007-05-02       Impact factor: 0.444

10.  Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia.

Authors:  Jubao Duan; Maria Martinez; Alan R Sanders; Cuiping Hou; Naruya Saitou; Takashi Kitano; Bryan J Mowry; Raymond R Crowe; Jeremy M Silverman; Douglas F Levinson; Pablo V Gejman
Journal:  Am J Hum Genet       Date:  2004-08-24       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.